Author

Antonino Missineo

Observed name: A. Missineo

Institution: IRBM

Observed institutions: University of Pavia, IRBM

ORCID: 0000-0002-4583-4290

Observed ORCID: 0000-0002-4583-4290

OpenAlex ID: A5025064130

Toll-Like Receptors (TLRs) in Innate Immune Defense Against Staphylococcus Aureus

2011 · Giampiero Pietrocola, Carla Renata Arciola, et al. · The International Journal of Artificial Organs · 82

Identification and binding mode of a novel Leishmania Trypanothione reductase inhibitor from high throughput screening

2018 · Lorenzo Turcano, Esther Torrente, et al. · PLoS neglected tropical diseases · 76

PDF

NRF2 activation by reversible KEAP1 binding induces the antioxidant response in primary neurons and astrocytes of a Huntington's disease mouse model

2020 · Daniele Moretti, Sara Tambone, et al. · Free Radical Biology and Medicine · 53

IsdC from Staphylococcus lugdunensis Induces Biofilm Formation under Low-Iron Growth Conditions

2014 · Antonino Missineo, Antonella Di Poto, et al. · Infection and Immunity · 51

PDF

Nuclear factor (erythroid-derived 2)-like 2 (NRF2) drug discovery: Biochemical toolbox to develop NRF2 activators by reversible binding of Kelch-like ECH-associated protein 1 (KEAP1)

2017 · Alberto Bresciani, Antonino Missineo, et al. · Archives of Biochemistry and Biophysics · 49

Optimization of linear and cyclic peptide inhibitors of KEAP1-NRF2 protein-protein interaction

2020 · Stefania Colarusso, Daniele De Simone, et al. · Bioorganic & Medicinal Chemistry · 29

Discovery of a Novel Series of Imidazopyrazine Derivatives as Potent SHP2 Allosteric Inhibitors

2023 · Esther Torrente, Valentina Fodale, et al. · ACS Medicinal Chemistry Letters · 27

PDF

Oligomerization, albumin binding and catabolism of therapeutic peptides in the subcutaneous compartment: An investigation on lipidated GLP-1 analogs

2022 · Mariana Gallo, Domitilla Vanni, et al. · Journal of Pharmaceutical and Biomedical Analysis · 26

Spiro-containing derivatives show antiparasitic activity against Trypanosoma brucei through inhibition of the trypanothione reductase enzyme

2020 · Lorenzo Turcano, Theo Battista, et al. · PLoS neglected tropical diseases · 22

PDF

High Affinity Binders to EphA2 Isolated from Abdurin Scaffold Libraries; Characterization, Binding and Tumor Targeting

2015 · Christopher Ullman, Pascale Mathonet, et al. · PLoS ONE · 17

PDF

Molecular Characterization of the Multiple Interactions of SpsD, a Surface Protein from Staphylococcus pseudintermedius, with Host Extracellular Matrix Proteins

2013 · Giampiero Pietrocola, Joan A. Geoghegan, et al. · PLoS ONE · 17

PDF

SAR evolution towards potent C-terminal carboxamide peptide inhibitors of Zika virus NS2B-NS3 protease

2022 · Stefania Colarusso, Federica Ferrigno, et al. · Bioorganic & Medicinal Chemistry · 11

An allosteric inhibitor of the Zika virus NS2B-NS3 protease with oral efficacy in mouse models

2026 · Jesus M. Ontoria, Esther Torrente, et al. · Nature Communications · 6

PDF

Identification by High-Throughput Screening of Pseudomonas Acyl–Coenzyme A Synthetase Inhibitors

2017 · Lorenzo Turcano, Daniela Visaggio, et al. · SLAS DISCOVERY · 2

A21 Development of an Nrf2-KEAP1 protein-protein disruptor for proof of concept

2016 · Alberto Bresciani, Mauro Cerretani, et al. · Journal of Neurology Neurosurgery & Psychiatry · 2

Development and validation of highly selective monoclonal antibodies for the detection of huntingtin neoepitopes

2026 · Antonino Missineo, Licia Tomei, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1

PDF

Discovery and Preclinical Characterization of I-0436650, a Selective SHP2 Allosteric Inhibitor for RAS-Driven Cancers

2026 · Alina Ciammaichella, Francesca Puca, et al. · Journal of Medicinal Chemistry

Abstract 4773: AM E3-SG3249, a first-in-class α-CRLF2 antibody-drug conjugate for the treatment of CRLF2-rearranged Ph-like B-ALL

2025 · Claudia Dall'Armi, Valentina Di Biasio, et al. · Cancer Research

Abstract 1975: Discovery of I-1000233, a potent, selective and brain permeable SHP2 allosteric inhibitor

2024 · Francesca Puca, Danilo Fabbrini, et al. · Cancer Research

Abstract 2610: Discovery of AM E3: A novel α-TLSPR monoclonal antibody for the ADC treatment of CRLF2-rearranged Ph-like B-ALL

2024 · Claudia Dall'Armi, Valentina Di Biasio, et al. · Cancer Research

Discovery of I-0436650, a potent and selective SHP2 allosteric inhibitor for the treatment of RAS driven solid tumors

2022 · F. Puca, V. Fodale, et al. · European Journal of Cancer

PDF

Development of a Broadly Applicable Assay for Measurement of Glycan-Directed Enzymatic Activity

2018 · Alberto Bresciani, Ottavia Cecchetti, et al. · SLAS DISCOVERY

PDF

Works count: 22

Citation count: 471

H-index: 11

I10-index: 12